RecruitingPhase 2NCT07370207

Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region

A Phase 2 Multi-center, Randomized, Open-label Study to Assess the Efficacy and Safety of AHB-137 in Nucleos(t)Ide Analogue-treated Participants With HBeAg Negative Chronic Hepatitis B in the Asia Pacific Region

Sponsor

AusperBio Therapeutics Inc.

Enrollment

84 participants

Start Date

Mar 6, 2026

Study Type

INTERVENTIONAL

Conditions

Hepatitis B, Chronic

Summary

This study is a randomized, open-label, multicenter phase 2 clinical trial to evaluate the efficacy and safety of AHB-137 injection in participants with HBeAg-negative CHB treated with Nucleos(t)ide Analogue (NAs).

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called AHB-137 for people with hepatitis b, chronic. The study is currently recruiting participants at 8 locations. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAHB-137

Subcutaneous injection

Locations(8)

St Vincents Hospital Melbourne

Fitzroy, Victoria, Australia

Queen Mary Hospital - PPDS

Hong Kong, China

New Zealand Clinical Research

Grafton, Auckland, New Zealand

National University Hospital - Singapore

Singapore, Singapore

Asan Medical Center

Seoul, South Korea

Chiayi Christian Hospital

Chiayi City, Taiwan

E-DA Hospital

Kaohsiung City, Taiwan

National Taiwan University Hospital

Taipei, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07370207

Related Trials

Sequential PEG-IFN for HBV After Ending RNA-targeted Regimens

NCT06923280

Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+D

NCT074918482 locations

Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B

NCT066802324 locations

Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection [VISION]

NCT062164701 location

The HOPE Study: Characterizing Patients With Hepatitis B and C

NCT029952522 locations